Cargando…

Regulation of TRAIL expression by PRAME and EZH2 as potential therapeutic target against solid tumors

Detalles Bibliográficos
Autores principales:	Mello, Barbara P, de Carvalho, Daniel D, Campos, Antonio HJFM, Soares, Fernando A, Amarante-Mendes, Gustavo P
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2013
Materias:	Poster Presentation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3624152/ http://dx.doi.org/10.1186/1753-6561-7-S2-P10

Ejemplares similares

Recombinant trail: a synergistic effect in myeloid leukemias
por: Carvalho, Filipa, et al.
Publicado: (2010)

Trials trail a long tail
por: Clarke, Mike
Publicado: (2015)

HMB45/PRAME, a Novel Double Staining for the Diagnosis of Melanocytic Neoplasms: Technical Aspects, Results, and Comparison With Other Commercially Available Staining (PRAME and Melan A/PRAME)
por: Grillini, Marco, et al.
Publicado: (2022)

Immunogenicity of recurrent mutations in MYD88 and EZH2 in non-Hodgkin lymphomas
por: Nielsen, Julie S, et al.
Publicado: (2015)

A Comprehensive Preclinical Model Evaluating the Recombinant PRAME Antigen Combined With the AS15 Immunostimulant to Fight Against PRAME-expressing Tumors
por: Gérard, Catherine, et al.
Publicado: (2015)

Signaling pathways involved in TRAIL-induced rheumatoid arthritis synovial fibroblast proliferation
por: Morel, J, et al.
Publicado: (2005)

PRAME expression is similar in scar and desmoplastic melanoma
por: Plotzke, Jaclyn M., et al.
Publicado: (2022)

PRAME Expression in Mucosal Melanoma of the Head and Neck Region
por: Ricci, Costantino, et al.
Publicado: (2023)

HTLV-1 Tax disrupts the host epigenome by interacting with a Polycomb group protein EZH2
por: Fujikawa, Dai, et al.
Publicado: (2014)

The Expansion of the PRAME Gene Family in Eutheria
por: Chang, Ti-Cheng, et al.
Publicado: (2011)

IL-1 but not IL-18 induces osteoprotegerin and TRAIL in rheumatoid arthritis synovial fibroblasts
por: Morel, J, et al.
Publicado: (2003)

Therapeutic targeting of PRAME with (mTCR)CAR T cells in acute myeloid leukemia
por: Kirkey, Danielle C., et al.
Publicado: (2022)

Natural killer cells facilitate PRAME-specific T-cell reactivity against neuroblastoma
por: Spel, Lotte, et al.
Publicado: (2015)

Scientific evidence reveals conjoined etiology in spinal deformation and the need for etiology based treatment. Insight in a trail
por: Van Loon, Piet, et al.
Publicado: (2014)

PRAME expression and clinical outcome of breast cancer
por: Epping, M T, et al.
Publicado: (2008)

Lack of PRAME Expression in Cutaneous T-Cell Lymphomas
por: Bui, Chau M., et al.
Publicado: (2021)

PRAME induces genomic instability in uveal melanoma
por: Kurtenbach, Stefan, et al.
Publicado: (2023)

A TRAIL-R1-specific ligand in combination with doxorubicin selectively targets primary breast tumour cells for apoptosis
por: Twiddy, D, et al.
Publicado: (2010)

PReS-FINAL-2148: Rheumates@work a cognitive behavioural internet based intervention promoting physical activity in children with juvenile idiopathic arthritis: preliminary results of a randomized clinical trail
por: Bos, J, et al.
Publicado: (2013)

Tumor-associated antigen Prame targets tumor suppressor p14/ARF for degradation as the receptor protein of CRL2(Prame) complex
por: Zhang, Wenjuan, et al.
Publicado: (2021)

Overexpressed PRAME is a potential immunotherapy target in sarcoma subtypes
por: Roszik, Jason, et al.
Publicado: (2017)

PRAME expression and promoter hypomethylation in epithelial ovarian cancer
por: Zhang, Wa, et al.
Publicado: (2016)

Metastatic PRAME-Expressing Juvenile Spitzoid Melanoma on the Buttock
por: Muto, Yusuke, et al.
Publicado: (2020)

PRAME protein expression in DICER1‐related tumours
por: Thorner, Paul S, et al.
Publicado: (2022)

PRAME Immunocytochemistry for the Diagnosis of Melanoma Metastases in Cytological Samples
por: Ronchi, Andrea, et al.
Publicado: (2022)

PRAME Expression as Helpful Immunohistochemical Marker in Rhabdoid Melanoma
por: Glutsch, Valerie, et al.
Publicado: (2022)

PRAME protein expression in DICER1‐related tumours
por: Thorner, Paul S, et al.
Publicado: (2022)

Genetic mechanism for the loss of PRAME in B cell lymphomas
por: Mraz, Marek
Publicado: (2022)

PRAME and CTCFL-reactive TCRs for the treatment of ovarian cancer
por: van Amerongen, Rosa A., et al.
Publicado: (2023)

Molecular and clinicopathological implications of PRAME expression in adult glioma
por: Le, Minh-Khang, et al.
Publicado: (2023)

Intrinsic disorder in PRAME and its role in uveal melanoma
por: Antonietti, Michael, et al.
Publicado: (2023)

Cardiogenic shock: an experimental animal model
por: Tanamati, C, et al.
Publicado: (2005)

PRAME and HLA Class I expression patterns make synovial sarcoma a suitable target for PRAME specific T-cell receptor gene therapy
por: Luk, Sietse J, et al.
Publicado: (2018)

Production of proteolytic extract by Aspergillus oryzae grown by solid state fermentation using canola meal as substrate
por: Oliveira Pascoal, Natália Lima de, et al.
Publicado: (2014)

Ex-vivo expanded human NK cells mediate cytotoxicity and cytokine release against allogeneic cancer cell line by direct recognition and antibody directed cellular cytotoxicity: therapeutic potential use of NK cells for blood and solid tumors
por: Liacini, Abdelhamid, et al.
Publicado: (2014)

Targeting high-risk pediatric solid tumors with CAR T cells directed against ALK (anaplastic lymphoma kinase, CD246)
por: Walker, Alec, et al.
Publicado: (2014)

Efficacy of adoptive transfer of expanded fetal liver-derived precursor syngeneic and allogeneic murine NK cells against solid tumors
por: Liang, Xiaoyan, et al.
Publicado: (2015)

Synergy of therapeutic vaccination against HPV16 oncogenic proteins and standard chemotherapeutics
por: Melief, Cornelis J, et al.
Publicado: (2014)

C-reactive protein ratio response patterns in pediatric sepsis: a cohort study - preliminary results
por: Soares Lanziotti, V, et al.
Publicado: (2015)

P1262: EZH2 INHIBITORS MEDIATE PLATINUM RESISTANCE BY ENHANCED EFFLUX
por: Groß, E., et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_umgaki4cll1no8j1vl4q2b4sr0